Literature DB >> 8883950

GDNF mRNA levels are induced by FGF-2 in rat C6 glioblastoma cells.

C Suter-Crazzolara1, K Unsicker.   

Abstract

Glia cell line-derived neurotrophic factor (GDNF), a recently cloned member of the transforming growth factor-beta (TGF-beta) superfamily, has been implicated in the survival, morphological and functional differentiation of midbrain dopaminergic neurons and motoneurons in vitro and in vivo. The factor may thus have utility in the treatment of various human neurodegenerative disorders. Mechanisms regulating expression of GDNF in normal and diseased brain as a possible means to increase the local availability of GDNF are only beginning to be explored. We have established and employed a competitive reverse transcriptase-polymerase chain reaction (RT-PCR) to study and compare levels of expression of GDNF mRNA in several cell types and to investigate its regulation. GDNF expression was clearly evident in primary cultured astrocytes, the glioma B49 and C6 cell, but less pronounced in the Schwannoma RN22 cell lines. Little or no signal could be observed in neuroblastoma cell lines (IMR32, LAN-1) or the pheochromocytoma cell line PC12, emphasizing the glial character of this factor. Using the C6 cell line we found that fibroblast growth factor-2 (FGF-2; bFGF) can increase GDNF mRNA levels, whereas FGF-1, platelet-derived growth factor (PDGF), and vasoactive intestinal polypeptide (VIP) are apparently ineffective. Several other factors (forskolin, kainic acid, triiodothyronine dexamethasone, GDNF, TGF-beta 1, and interleukin-6) appear to have slightly negative effects on GDNF mRNA levels at the concentrations tested. To further explore the relationship between FGF-2 and GDNF, we also addressed the question whether GDNF, like FGF-2, may have an effect on C6 cell proliferation. We conclude that (1) glial and glial tumor cells, rather than neuronal cell lines, express GDNF, (2) that FGF-2 has a prominent inductive effect on GDNF expression and (3) that GDNF stimulates C6 cell proliferation. Finally, these data suggest that neurotrophic actions of FGF-2 in mixed glial-neuronal cell cultures might be mediated in part by GDNF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883950     DOI: 10.1016/0169-328x(96)00089-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  13 in total

1.  Tricyclic antidepressant amitriptyline activates fibroblast growth factor receptor signaling in glial cells: involvement in glial cell line-derived neurotrophic factor production.

Authors:  Kazue Hisaoka; Mami Tsuchioka; Ryoya Yano; Natsuko Maeda; Naoto Kajitani; Norimitsu Morioka; Yoshihiro Nakata; Minoru Takebayashi
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Glial cell line-derived neurotrophic factor induces cell proliferation in the mouse urogenital sinus.

Authors:  Hyun-Jung Park; Eric C Bolton
Journal:  Mol Endocrinol       Date:  2014-12-30

3.  Nerve growth factor plays a divergent role in mediating growth of rat C6 glioma cells via binding to the p75 neurotrophin receptor.

Authors:  Carla Weis; Bettina Wiesenhofer; Christian Humpel
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

4.  Inactivation of fibroblast growth factor receptor signaling in myelinating glial cells results in significant loss of adult spiral ganglion neurons accompanied by age-related hearing impairment.

Authors:  S J Wang; M Furusho; C D'Sa; S Kuwada; L Conti; D K Morest; R Bansal
Journal:  J Neurosci Res       Date:  2009-11-15       Impact factor: 4.164

5.  Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity.

Authors:  Miki Furusho; Jeffrey L Dupree; Melissa Bryant; Rashmi Bansal
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

6.  Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons.

Authors:  Xuefei Wu; Po See Chen; Shannon Dallas; Belinda Wilson; Michelle L Block; Chao-Chuan Wang; Harriet Kinyamu; Nick Lu; Xi Gao; Yan Leng; De-Maw Chuang; Wanqin Zhang; Ru Band Lu; Jau-Shyong Hong
Journal:  Int J Neuropsychopharmacol       Date:  2008-07-09       Impact factor: 5.176

7.  Egr-1 is necessary for fibroblast growth factor-2-induced transcriptional activation of the glial cell line-derived neurotrophic factor in murine astrocytes.

Authors:  Soon Young Shin; Haengseok Song; Chang Gun Kim; Yang-Kyu Choi; Kyoung Sun Lee; Seung-Jae Lee; He-Jin Lee; Yoongho Lim; Young Han Lee
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

8.  Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming.

Authors:  Viktoria Gudi; Jelena Škuljec; Özlem Yildiz; Konstantin Frichert; Thomas Skripuletz; Darius Moharregh-Khiabani; Elke Voss; Kirsten Wissel; Sabine Wolter; Martin Stangel
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

9.  Fasciculation and guidance of spinal motor axons in the absence of FGFR2 signaling.

Authors:  Rosa-Eva Huettl; Teresa Haehl; Andrea B Huber
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

10.  Glial-derived neurotrophic factor in human airway smooth muscle.

Authors:  Sangeeta Bhallamudi; Benjamin B Roos; Jacob J Teske; Sarah A Wicher; Andrea McConico; Christina M Pabelick; Venkatachalem Sathish; Y S Prakash
Journal:  J Cell Physiol       Date:  2021-06-25       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.